ADVANCED TUMORS
Clinical trials for ADVANCED TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo targets Hard-to-Treat tumors
Disease control CompletedThis early-phase study tested a new drug called RiMO-301 given together with radiation in 32 people with advanced tumors that could not be cured by standard treatments. The drug was injected directly into the tumor to see what dose is safe and tolerable. The goal was to find the …
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
Immunotherapy cocktail shows promise in Hard-to-Treat cancers
Disease control CompletedThis study tested a new immunotherapy drug, ezabenlimab (BI 754091), combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the combination could shrink or eliminate tumors. Participants received treatment as long as …
Matched conditions: ADVANCED TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 19, 2026 11:48 UTC